Hebrew University startup ViroBlock has reported preliminary success of its platform for rapidly generating anti-viral therapies. Its channel blockers inhibit proteins expressed by current and emerging viruses, including COVID-19 and variants, influenza, Zika, West Nile, Hepatitis B and more.
A platform to eliminate all viruses
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.